Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 228

    1.

    Association of the p22phox component of NAD(P)H oxidase with susceptibility to diabetic nephropathy in patients with type 1 diabetes.

    Hodgkinson AD, Millward BA, Demaine AG.

    Diabetes Care. 2003 Nov;26(11):3111-5.PMID: 14578247 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Polymorphisms of the glucose transporter (GLUT1) gene are associated with diabetic nephropathy.

    Hodgkinson AD, Millward BA, Demaine AG.

    Kidney Int. 2001 Mar;59(3):985-9.PMID: 11231353 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Relation between development of nephropathy and the p22phox C242T and receptor for advanced glycation end product G1704T gene polymorphisms in type 2 diabetic patients.

    Matsunaga-Irie S, Maruyama T, Yamamoto Y, Motohashi Y, Hirose H, Shimada A, Murata M, Saruta T.

    Diabetes Care. 2004 Feb;27(2):303-7.PMID: 14747204 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes.

    Wang Y, Ng MC, Lee SC, So WY, Tong PC, Cockram CS, Critchley JA, Chan JC.

    Diabetes Care. 2003 Aug;26(8):2410-5.PMID: 12882871 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus.

    Yang B, Cross DF, Ollerenshaw M, Millward BA, Demaine AG.

    J Diabetes Complications. 2003 Jan-Feb;17(1):1-6.PMID: 12505748 [PubMed - indexed for MEDLINE]Related articles

    6.

    No association between genetic polymorphisms in NAD(P)H oxidase p22phox and paraoxonase 1 and colorectal cancer risk.

    Van Der Logt EM, Janssen CH, Van Hooijdonk Z, Roelofs HM, Wobbes T, Nagengast FM, Peters WH.

    Anticancer Res. 2005 Mar-Apr;25(2B):1465-70.PMID: 15865106 [PubMed - indexed for MEDLINE]Related articles

    7.

    Polymorphisms of the aldose reductase gene and susceptibility to retinopathy in type 1 diabetes mellitus.

    Demaine A, Cross D, Millward A.

    Invest Ophthalmol Vis Sci. 2000 Dec;41(13):4064-8.PMID: 11095596 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment.

    Etoh T, Inoguchi T, Kakimoto M, Sonoda N, Kobayashi K, Kuroda J, Sumimoto H, Nawata H.

    Diabetologia. 2003 Oct;46(10):1428-37. Epub 2003 Sep 12.PMID: 13680125 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes]

    Fanelli A, Hadjadj S, Gallois Y, Fumeron F, Betoule D, Grandchamp B, Marre M.

    Arch Mal Coeur Vaiss. 2002 Jul-Aug;95(7-8):701-8. French. PMID: 12365083 [PubMed - indexed for MEDLINE]Related articles

    10.

    Polymorphism in the 5'-end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type I diabetes.

    Heesom AE, Hibberd ML, Millward A, Demaine AG.

    Diabetes. 1997 Feb;46(2):287-91.PMID: 9000706 [PubMed - indexed for MEDLINE]Related articles

    11.

    Relationship of p22phox C242T polymorphism with nephropathy in type 2 diabetic patients.

    Santos KG, Canani LH, Gross JL, Tschiedel B, Souto KE, Roisenberg I.

    J Nephrol. 2005 Nov-Dec;18(6):733-8.PMID: 16358232 [PubMed - indexed for MEDLINE]Related articles

    12.

    Association of NAD(P)H oxidase p22 phox gene variation with advanced carotid atherosclerosis in Japanese type 2 diabetes.

    Hayaishi-Okano R, Yamasaki Y, Kajimoto Y, Sakamoto K, Ohtoshi K, Katakami N, Kawamori D, Miyatsuka T, Hatazaki M, Hazama Y, Hori M.

    Diabetes Care. 2003 Feb;26(2):458-63.PMID: 12547880 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    NAD(P)H oxidase p22phox Gene C242T polymorphism and lipoprotein oxidation.

    Nakano T, Matsunaga S, Nagata A, Maruyama T.

    Clin Chim Acta. 2003 Sep;335(1-2):101-7.PMID: 12927691 [PubMed - indexed for MEDLINE]Related articles

    14.

    Relationship between common functional polymorphisms of the p22phox gene (-930A > G and +242C > T) and nephropathy as a result of Type 2 diabetes in a Chinese population.

    Lim SC, Goh SK, Lai YR, Tee WW, Koh A, Xu XH, Wu YS, Yap E, Subramaniam T, Sum CF.

    Diabet Med. 2006 Sep;23(9):1037-41.PMID: 16922713 [PubMed - indexed for MEDLINE]Related articles

    15.

    Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis.

    Guzik TJ, West NE, Black E, McDonald D, Ratnatunga C, Pillai R, Channon KM.

    Circulation. 2000 Oct 10;102(15):1744-7.PMID: 11023926 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Functional effects of NAD(P)H oxidase p22(phox) C242T mutation in human leukocytes and association with thrombotic cerebral infarction.

    Shimo-Nakanishi Y, Hasebe T, Suzuki A, Mochizuki H, Nomiyama T, Tanaka Y, Nagaoka I, Mizuno Y, Urabe T.

    Atherosclerosis. 2004 Jul;175(1):109-15.PMID: 15186954 [PubMed - indexed for MEDLINE]Related articles

    17.

    (AC)(n) polymorphism of aldose reductase gene and diabetic microvascular complications in type 2 diabetes mellitus.

    Park HK, Ahn CW, Lee GT, Kim SJ, Song YD, Lim SK, Kim KR, Huh KB, Lee HC.

    Diabetes Res Clin Pract. 2002 Feb;55(2):151-7.PMID: 11796181 [PubMed - indexed for MEDLINE]Related articles

    18.

    Haplotype analysis of NAD(P)H oxidase p22 phox polymorphisms in end-stage renal disease.

    Doi K, Noiri E, Nakao A, Fujita T, Kobayashi S, Tokunaga K.

    J Hum Genet. 2005;50(12):641-7. Epub 2005 Oct 8.PMID: 16215641 [PubMed - indexed for MEDLINE]Related articles

    19.

    Association of aldose reductase gene Z+2 polymorphism with reduced susceptibility to diabetic nephropathy in Caucasian Type 1 diabetic patients.

    Lajer M, Tarnow L, Fleckner J, Hansen BV, Edwards DG, Parving HH, Boel E.

    Diabet Med. 2004 Aug;21(8):867-73.PMID: 15270790 [PubMed - indexed for MEDLINE]Related articles

    20.

    No association between a genetic variant of the p22(phox) component of NAD(P)H oxidase and the incidence and progression of IgA nephropathy.

    Wolf G, Panzer U, Harendza S, Wenzel U, Stahl RA.

    Nephrol Dial Transplant. 2002 Aug;17(8):1509-12.PMID: 12147803 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data